Allergic Rhinitis Drugs Market to Hit USD 2.2 Billion by 2028 | Allergic Rhinitis Drugs Industry CAGR 3% During 2021-2028 Exclusive Report by Vantage Market Research

·7 min read

WASHINGTON, Nov. 30, 2021 (GLOBE NEWSWIRE) -- The Global Allergic Rhinitis Drugs Market size is expected to reach USD 2.2 Billion by 2028, exhibiting a CAGR of 3% during the forecast period. Increased prevalence of perennial Allergic Rhinitis and growing patient pool is projected to propel the demand of this Allergic Rhinitis treatment during the projected period, states Vantage Market Research, in a report, titled “Allergic Rhinitis Drugs Market by Type (Intranasal Antihistamines, Intranasal Corticosteroids, Oral Antihistamines, Immunotherapy and Vaccines) by Application (Non-Allergic Rhinitis, Mixed Rhinitis, Seasonal Allergic Rhinitis, Perennial Allergic Rhinitis), by Region (North America, Europe, Asia Pacific, Latin America and Middle East & Africa): Global Market Assessment, 2021 – 2028.” The market size stood at USD 1.7 Billion in 2020.

The COVID-19 outbreak has affected various industries worldwide. The Allergic Rhinitis Drugs Market is no exception. Governments across the world took severe actions like border seals, lockdown, and implementing strict social distancing measures, in order to stop swift spread of COVID-19. These actions led to severe impact on the global economy impairing various industries. The impact of COVID-19 on the market demand is considered while estimating the current and forecast market size and growth trends of the market for all the regions and countries based on the following data-points:

  1. Impact Assessment of COVID-19 Pandemic

    1. North America

    2. Europe

    3. Asia Pacific

    4. Latin America

    5. Middle East & Africa

  2. Quarterly Market Revenue Forecast by Region 2020 & 2021

  3. Key Strategies Undertaken by Companies to Tackle COVID-19

  4. Long Term Dynamics

  5. Short Term Dynamics

Request Your Free Sample Report of Global Allergic Rhinitis Drugs Market @
Our free sample reports Includes:

  • In-depth Industry Analysis, Introduction, Overview, and COVID-19 Pandemic Outbreak.

  • Impact Analysis 130+ Pages Research Report (Including latest research)

  • Provide chapter-wise guidance on request 2020 Updated Regional Analysis with Graphical Representation of Trends, Size, & Share, Includes Updated List of figures and tables.

  • Updated Report Includes Major Market Players with their Sales Volume, Business Strategy and Revenue Analysis by using VMR research methodology

The report on Allergic Rhinitis Drugs Market highlights:

  • Assessment of the market

  • Premium Insights

  • Competitive Landscape

  • COVID Impact Analysis

  • Historic Data, Estimates and Forecast

  • Company Profiles

  • Global and Regional Dynamics

Market Overview:

Increase spending towards healthcare diseases boost the market

Since from last few decades, it has been noticed that there is increased amount of spending towards healthcare diseases. This in turns increases the awareness about the availability of various treatments to treat various diseases. This increased healthcare spending is resulted into the high demand of good quality drugs and fastest diagnostic methodologies for fast recovery of any disease. That is why the demand of allergic rhinitis drugs in the market is more and in turns help to drive the market growth in coming years. Another major factors to bolstering the growth of Allergic Rhinitis Drugs Market are Rising healthcare expenditure, high demand of new technological investment, increasing diagnostic methods to treat various diseases and increasing rate of awareness about availability of treatments during the forecast period.

Get detailed COVID-19 impact analysis on the Allergic Rhinitis Drugs Market-

Regional Analysis:

Large amount of R&D expenditure accounted fastest growth in North America

North America dominates the allergic rhinitis treatment market during the forecast period, owing the large amount of R&D expenditure for the development of allergy treatment, rising prevalence of food allergies and huge healthcare investments. Asia Pacific region is accounted the substantial growth of the Allergic Rhinitis Drugs Market during the forecast period. This is mainly due to the rising healthcare expenditure and high disposable income. High demand of advance technology and high prevalence of respiratory disease are fuelling the market growth of Allergic Rhinitis Drugs Market in the region.

List of Prominent Players in the Artificial Intelligence (AI) in Retail Market:

Sr. No.




Allergy Therapeutics

Worthing, West Sussex, UK


Dr Reddy's Laboratories

Hyderabad; Telangana, India


GlaxoSmithKline plc

Brentford, United Kingdom


Johnson & Johnson Merck & Co.

Kenilworth, New Jersey


Mylan NV

Canonsburg, Pennsylvania, United States


Pfizer Inc.

New York, United States



Paris, France


Stallergenes Greer

Antony, France


Sun Pharmaceuticals

Goregaon, Mumbai

Important questions answered in this report:

  • What is the estimated market size and growth rate of the Allergic Rhinitis Drugs Market?

  • Which segments are included in the Allergic Rhinitis Drugs Market?

  • Which top companies are active in the Allergic Rhinitis Drugs Market?

  • What are the major driving factors for the growth of the Allergic Rhinitis Drugs Market?

  • How can I get free sample reports or study of Allergic Rhinitis Drugs Market?

Recent Developments in the Industry:

1. April 2021: ALK announced the successful approval from FDA regarding short ragweed pollen allergen extract for the treatment of patients aged 5 to 65 years with short ragweed pollen-induced allergic rhinitis.

2. June 2019: ALK announced the successful marketing of sublingual allergy immunotherapy (SLIT) tablet in 17 European countries.

Browse 306 market data Tables and 35 Figures spread through Pages and in-depth TOC on "Allergic Rhinitis Drugs Market by Type (Intranasal Anthistamines, Intranasal Corticosteroids, Oral Antihistamines, Immunotherapy and Vaccines) by Application (Non-Allergic Rhinitis, Mixed Rhinitis, Seasonal Allergic Rhinitis, Perennial Allergic Rhinitis) , by Region (North America, Europe, Asia Pacific, Latin America and Middle East & Africa): Global Market Assessment, 2021 – 2028" Report at

This report provides the worldwide allergy rhinitis drugs market analyses and researches the allergy rhinitis drugs development status. It also focuses on the highest players within the global allergy rhinitis drugs market.

Report Attribute


Base Year


Historic Years

2016 - 2019

Forecast Years

2021 - 2028

Segments Covered

Quantitative Data - Units

Revenue in USD Million/Billion and CAGR from 2021 to 2028

Regions Covered

North America, Europe, Asia Pacific, Latin America, and Middle East & Africa, and Rest of World

Countries Covered

U.S., Canada, Mexico, U.K., Germany, France, Italy, Spain, China, India, Japan, South Korea, Brazil, Argentina, GCC Countries, and South Africa, among others

Report Coverage

Market growth drivers, restraints, opportunities, Porter’s five forces analysis, PEST analysis, value chain analysis, regulatory landscape, market attractiveness analysis by segments and region, company market share analysis, and COVID-19 impact analysis.

Table of Content:

  1. Chapter No. 1: Introduction

    1. Report Scope

    2. Objectives of the Study

    3. USP & Key Offerings

    4. Target Audience

    5. Vantage Market Research Report Guidance/Walk-through

  2. Chapter No. 2: Premium Insights

    1. Market Snapshot

    2. Top Investment Pockets

      1. Market Attractiveness Analysis, By Type

      2. Market Attractiveness Analysis, By Application

      3. Market Attractiveness Analysis, By North America

    3. Insights from Primary Respondents

  3. Chapter No. 3: Key Market Dynamics

    1. Introduction

    2. Market Drivers

    3. Market Restraints

    4. Market Opportunities

    5. Porter’s Five Forces Analysis

    6. PEST Analysis

    7. Regulatory Landscape

Browse Latest Research Reports by VMR:

About Us:

We, at (VMR) Vantage Market Research, provide quantified B2B high quality research on more than 20,000 emerging markets, in turn, helping our clients map out constellation of opportunities for their businesses. We, as a competitive intelligence market research and consulting firm provide end to end solutions to our client enterprises to meet their crucial business objectives. Our clientele base spans across 70% of Global Fortune 500 companies. The company provides high quality data and market research services. The company serves various enterprises and clients in a wide variety of industries. The company offers detailed reports on multiple industries including Chemical Materials and Energy, Food and Beverages, Healthcare Technology, etc. The company’s experienced team of Analysts, Researchers, and Consultants use proprietary data sources and numerous statistical tools and techniques to gather and analyse information.

Contact us

Eric Kunz

6218 Georgia Avenue NW Ste 1 - 564

Washington DC 20011-5125

United States Tel: +1 202 380 9727



Latest Vantage Market Research Press Releases @

Latest Vantage Market Research Blog @

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting